4F-4-MAR: CHEMICAL INFORMATION, RESEARCH STATUS, RISKS AND LEGAL ISSUES

What Is 4F-4-MAR?

4F-4-MAR is a synthetic psychoactive substance of the aminorex class of chemicals. It has the systematic chemical name of 5-(4-fluorophenyl)-4-methyl-4,5-dihydrooxazol-2-amine. Other names reported for the compound include 4-fluoro-4-methylaminorex, para-fluoro-4-methylaminorex, 4F-MAR and 4-FPO.

The pharmacological and toxicological profile of this compound is poorly characterised due to the lack of information. It is therefore not to be regarded as an approved medicine or dietary supplement.

Chemical Info 4F-4-MAR

4F-4-MAR has a fluorinated phenyl group in its molecular framework too. The compound is referred to by its systematic name in official Japanese regulatory documents, with alternative names also listed.

But chemical identification alone does not prove that a substance is safe for human use. In particular, products marketed under research-chemical names may contain unexpected substances or may not be correctly matched to their labels.

State of Research

Psychoactive substances that are emerging are being watched by regulatory and scientific bodies. It has been found in products marketed as novel recreational drugs and has been reported by a research project of the Japanese government. The same research also identified products where the contents advertized did not match what was actually found, highlighting the importance of laboratory analysis and product uncertainty.

Possible Dangers of 4F-4-MAR

4F-4-MAR is psychoactive, and there is no evidence of a safe level of use in humans or any accepted medical use. So, making an estimate of your personal dose from online reports can be very dangerous.

Official Japanese testing also reported serious adverse effects in animal experiments at higher experimental exposure levels, including death. These findings do not provide a dose recommendation for humans, but they do indicate that caution and further toxicological evaluation of the compound is needed.

Psychoactive compounds that are poorly characterised can have unpredictable neurological, cardiovascular and autonomic effects. These risks can be heightened by product contamination or mislabeling.

Is 4F-4-MAR Legal?

Laws differ from country to country and from time to time. 4F-4-MAR In Japan Scheduled in the relevant schedule Enforcement start: September 8, 2025 [x]

Japanese authorities say designated substances are limited to use outside of approved medical or other specifically permitted uses.

Some countries consider 4F-4MAR to be a controlled substance. As such, anyone researching 4F-4MAR should verify the current laws of their country before handling, possessing, importing or distributing the compound.

Safety Considerations 4F4-MAR

4F-4-MAR is not known to have any medical use, and therefore should not be used for self-medication. Also, information from forums or informal product listings does not provide confirmation of purity, identity, safety, or appropriate dose.

Researchers conducting legitimate laboratory research should adhere to all applicable institutional safety procedures, chemical-handling requirements, and local regulations. If you are accidentally exposed seek professional medical advice or contact poison control rather than relying on online dosing advice.

FAQs

What is 4F4-MAR?

4F-4-MAR is a synthetic psychoactive compound, also known as 4-fluoro-4-methylaminorex or 4F-MAR.

### Is 4F-4MAR an approved medicine?

Its status as a research chemical should not be taken to imply any established therapeutic indication.

4F4-MAR regulated?

Yes. For example, Japan added 4F-4-MAR to the list of controlled designated substances on September 8, 2025.

Is 4F4-MAR toxic to humans?

There is not enough evidence to know if it is safe in humans. Other regulatory research available suggests that the compound can cause serious adverse effects in experimental settings.

Summary

4F4-MAR is a synthetic psychoactive compound that is poorly characterised and warrants careful scientific and regulatory scrutiny. It is chemically identified, but there is limited human safety information so should not be presented as a medicine, supplement or established treatment. Moreover, the regulatory status differs from jurisdiction to jurisdiction. Laboratory controls, legal compliance and appropriate safety procedures are essential for responsible, accurate identification.